Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
24-26 February, 2026
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
Biotech ShowcaseBiotech Showcase
Not Confirmed
Not Confirmed
12-14 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 February, 2026
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Biotech ShowcaseBiotech Showcase
Industry Trade Show
Not Confirmed
12-14 January, 2026
Digital content

14 Jan 2026
// PRESS RELEASE

12 Jan 2026
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211241

15 Dec 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sentynl-therapeutics-announces-fda-acceptance-of-cutx-101-nda-resubmission-302642214.html

10 Dec 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sentynl-selects-mytomorrows-to-lead-managed-access-program-302637819.html

01 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/01/3159486/28889/en/Fortress-Biotech-and-Cyprium-Therapeutics-Announce-an-Update-on-the-NDA-for-CUTX-101.html

24 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/24/3155462/0/en/Er-Kim-Enters-Commercialization-Agreement-with-Sentynl-Therapeutics-for-Nulibry-fosdenopterin-and-Zokinvy-lonafarnib-Targeting-Ultra-Rare-Diseases.html
ABOUT THIS PAGE